Industry Analysis Reports | Health Care | Medical Devices

Friday, 7 May 2021

Animal Genetics Market Size, Share, Global Trends, Revenue Analysis, Business Insights, Developments and Opportunity Assessment by 2027

Market Overview

Animal genetics can be defined as the branch of science, which involves the study of gene variation and inheritance in wild and domestic animals. It is extensively used for genetic trait testing and DNA testing. The animal genetics market is predicted to propel owing to the ingesting of animal proteins and surging urban population across the globe, which has resulted in increased demand for meat products. The global animal genetics market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 8.4% during the forecast period (2018-2023).

The animal genetics market has witnessed a tectonic surge over the past few years due to increased consumption of animal proteins and rapid growth in urban population. The improvement of animal welfare, along with the advancement of genetic technologies, are driving the market globally. The market will experience tremendous growth due to increased adoption of genetic services in order to prevent business loss and genetic diseases. Significant investments in R&D activities and expansions by industry players will influence the market growth in the coming years.

On the flipside, the lack of skilled professionals, strict regulatory framework associated with genetic engineering, and the high cost of animal testing are predicted to slow down the market growth in the years to come.

Global Animal Genetics Market: Segmental Analysis

Based on animal genetic products, the market is segmented into live animals and genetic materials. The soaring demand for animal products like mutton, pork, coupled with rapid urbanization is estimated to propel the market growth in the segment. Rising adoption of artificial insemination in sheep, cattle, goats, and pigs will further enhance the market growth in the segment.

The animal genetics market by services is segmented into DNA typing, genetic disease tests, gene trait tests, and others. Soaring awareness of animal health, coupled with the surging number of genomic disease testing in order to prevent the loss of large-scale production will offer the market lucrative growth opportunities. The rising number of several animal genetic diseases and increased incidences of the zoonotic disease will drive the demand for genetic trait tests.

The end users segment comprises diagnostic centers, veterinary hospitals & clinics, research centers and institutes, and others.

Regional Frontiers

Geographically, the animal genetics market spans across America, Asia Pacific, Europe, and the Middle East & Africa.

Considering the global scenario, the animal genetics market was dominated by America in 2017 and is estimated to retain its pole position in the years to come. The growth is credited to the increased demand for animal products like mutton and pork. Rapid urbanization in the region has further encouraged the market growth in the region. Surging adoption of artificial insemination in sheep, cattle, goats, and pigs are further estimated to influence the market in America. In this region, North America commands the largest share due to surging adoption of pet ownership, adoption of the latest diagnostic technologies, and advanced animal healthcare base. Surging demand for safe livestock production, coupled with increased investment in R&D by the key players are likely to propel the market growth in the coming years.

Europe acquired the second position in the global market due to soaring awareness regarding animal health, an increasing number of animal genetic diseases, and surging incidences of zoonotic diseases. Mounting demand for well-bred animals with good quantitative genetic characteristics, along with the soaring demand for poultry and livestock products will propel the market in Europe.

Meanwhile, the Asia Pacific will register the fastest growth due to growth in livestock population, coupled with the advancements made in genetic testing tools and DNA typing. This has further resulted in increased demand for genetic trait tests and diagnostic testing. Moreover, the development of the healthcare sector in countries like India and China will make this market highly promising.

Competitive Dashboard

The top players operating in the animal genetics market include Genus (UK), Neogen Corporation (US), EW Group (Germany), URUS (US), CRV Holding B.V. (The Netherland), Groupe Grimaud (France), Zoetis (US), Topigs Norsvin (Netherlands), Animal Genetics (US), Envigo (US) Hendrix Genetics BV (The Netherland), vetGen (US), Alta Genetics (US), and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Biosimilars Market Share, Industry Size, Growth Analysis, Competitive Landscape, Segmentation, Future Prospects and Regional Forecast 2027

Market Synopsis

Market Research Future (MRFR) postulates that the biosimilars market is predicted to garner USD 3.35 billion, grabbing a CAGR of 26% throughout the forecast period (2017-2023). The augmenting incidences of several chronic diseases are estimated to favor the market growth. Biosimilars are referred to as a biological medical product which are identical copies of the original medical product. They are generally derived from a plant, bacteria, yeast, and other several processes. Biosimilars are neither generics nor treated like generic drugs. Also acknowledged as bio-pharmaceuticals, biosimilars differ from generics in the manufacturing process. They are produced by two main processes, recombinant DNA technology and controlled gene expression.

Market Potential and Pitfalls

With the augmenting incidences of several chronic diseases, growing demand for cheap medical products, and strategic collaborations leading to clinical trials and enhanced productivity, the global biosimilars market is estimated to flourish throughout the appraisal period. Biosimilars are extensively used in the treatment and prevention of chronic diseases like cancer, diabetes, autoimmune disease, cardiovascular diseases (CVDs), kidney failure, rheumatoid arthritis, hematological disease, hormone growth deficiency, and infectious disease. This is likely to create momentum to the market growth during the estimated period. Also, with the growth in the geriatric population, the demand for biosimilars is expected to trigger.

Biosimilars are constantly gaining prominence over other conventional biologics due to lesser cost as compared to the parent biological drugs. Moreover, different private and government bodies are promoting the use of biosimilars over synthetic drugs and conventional biologics, which is further propelling the growth of the market across the globe. Also, with the rapid growth in the pharmaceutical sector combined with the high cost of existing biological drugs, the market is anticipated to boom.

On the contrary, physician skepticism coupled with the lack of awareness regarding biosimilars is some of the top barriers likely to vitiate the market growth in the coming years. Additionally, complexity and high manufacturing cost can act as roadblocks to the mainstream production of biosimilars. Despite such hiccups, discounted prices of biosimilars will impact the overall biosimilar sales, as patients are the key beneficiaries.

Global Biosimilars Market: Segmental Analysis

The global biosimilars market has been segmented on the basis of product, application, and manufacturing.

By mode of product, the global biosimilars market has been segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and others. Among these, the recombinant glycosylated proteins segment is anticipated to occupy the largest share and is likely to retain its dominance. The growth is credited to the wide therapeutic area of such proteins coupled with the presence biosimilar version of monoclonal antibodies at much lower rates.

By mode of application, the global biosimilars market has been segmented into oncology, immune diseases, blood-related disorders, and others.

By mode of manufacturing, the global biosimilars market has been segmented into contract manufacturing and in-house manufacturing. Among these, the in-house manufacturing is presumed to occupy the largest share owing to the rising demand for cost-effective biosimilar products due to the augmenting incidences of several chronic diseases.

Regional Insights

Geographically, the biosimilars market span across regions namely, Europe, Asia Pacific, North America, and the Middle East & Africa.

Among all the regions, the European region is likely to dominate the global biosimilars market and is estimated to retain its dominance in the coming years. The growth is credited to the rising prevalence of diseases coupled with the growth in the geriatric population in this region. Moreover, advanced medical research and technological advancements are further triggering the demand for biosimilars in this region. The growth in the regional market is likely to be stimulated by patent expiry of biologic products combined with the launch of new biosimilars and the advent of new market participants.

The North American region is predicted to occupy the second largest share in the global market owing to technological advancements and extensive medical research. The market is mainly driven by the presence of large research labs such as Amgen, Sandoz, Teva Pharmaceutical, and others.

The Asia Pacific region is anticipated to emerge as the fastest-growing region owing to the immense economic development coupled with the booming biotechnology companies in this region. The country-specific markets in this region generating maximum revenue are India, Australia, South Korea, Japan, and China.

Industry Updates

February 19, 2019: Sandoz, a developer of biosimilar has recently announced the launch of their biosimilar adalimumab, Hyrimoz, in Spain. This biosimilar, referencing Humira, was authorized in the European Union for sale in July 2018. It has been approved for indications of reference adalimumab and is available in 40 mg doses for subcutaneous injection in pre-filled pen or a syringe form.

Competitive Dashboard

The prominent players operating the global biosimilars market are Biocon Ltd. (India), Eli Lilly (U.S.), Novartis (Switzerland), Celltrion Inc. (South Korea), Dr. Reddy’s Laboratories Ltd. (India), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Sandoz International GmbH (Germany), Astra Zeneca (U.K.), Amgen Inc. (U.S.), Samsung Bioepis (South Korea), F. Hoffmann-La Roche Ltd. (Switzerland), and Accord Healthcare (U.K.).

Read Complete Report @ https://www.marketresearchfuture.com/reports/biosimilars-market-1329

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Venous Blood Collection Devices Market 2027– Global Industry Size, share, Business Insights

Venous blood collection devices are used to collect sample from patients. Venous blood collection devices include needles, holders, collection tubes, and other devices. As per an in-depth research study published by Market Research Future (MRFR), the global venous blood collection devices market is estimated to post a CAGR of 9.3% over the forecast period of 2017-2023.

Substantial improvements made by medical device manufacturers towards safer blood collection. Advances in safety features and greater emphasis on the prevention of injury and reduction of bloodborne pathogen exposure fuel the growth of the global venous blood collection devices market. Moreover, medical device manufacturers are endeavoring towards product improvement and are diversifying their product portfolios as a growth strategy which also acts as a plus for the growth of the market. Crucial advancements include the introduction of plastic tubes, protective sliding needle shields, automatically retracting lancets, and winged-needle blood collection sets.

Chronic diseases are spreading at a brisk pace which has exerted massive burden on the healthcare sector. Screening for diseases induces high demand for diagnostic services which, in turn, triggers growth within the global venous blood collection devices market. Other factors which can accelerate the market growth include surging health & wellness awareness among the global populace, the rise in disposable income, and high healthcare expenditure.

On the flip side, venous blood collection devices are associated with the risk of needlestick injuries, contamination risks which can restrict the market growth. Additionally, pricing pressure on medical device manufacturers and substandard products from local medical device manufacturers can also undermine the growth of the market.

Segmentation

The global venous blood collection devices market has been segmented based on type, material, application, and end user.

By type, the global venous blood collection devices market has been segmented into blood collection tubes, needles, microfluidic system, vacuum blood collection system, micro-container tubes, micro-hematocrit tubes, warming devices, and others. Other venous blood collection devices include venous cannula and blood bags. The blood collection tube segment has been further segmented into plasma separation tube, heparin tube, serum separating tube, EDTA tube, and others.

By material, the global blood collection devices market has been segmented into plastic, glass, stainless steel, ceramic, and others.

By application, the global venous blood collection devices market has been segmented into vein blood gas sampling and intraoperative blood salvage. The vein blood gas sampling segment has been further segmented into diagnosis of disease and acid-base status monitoring.

By end user, the global venous blood collection devices market has been segmented into hospitals and clinics, blood donation centers, the point of care, diagnostic centers, and others.

Regional Analysis

By region, the global venous blood collection devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas is spearheading the global venous blood collection devices market. Rapid adoption of new surgical techniques and instruments within the healthcare sector in the region are substantiating the growth of the market. High demand for screening services coupled with high healthcare expenditure is driving the market growth. Moreover, greater awareness among consumers and favorable reimbursement landscape support the growth of the market.

Europe ranks second in the global venous blood collection devices market. High-income population and deep healthcare penetration in the region are favoring the growth of the market in Europe.

The expanding healthcare sector in the developing countries such as China and India generate high demand for venous blood collection devices in APAC. The rise in the geriatric population, the prevalence of chronic diseases which require screening services and increased demand for advanced blood sampling techniques are propelling the growth of the APAC venous blood collection devices market.

The MEA market is estimated to expand at a steady pace over the forecast period. Accelerated development of the healthcare sector and awareness programs launched by the government towards safe blood transfusion procedures are triggering growth within the MEA market.

Competitive Landscape

The key players in the global venous blood collection devices market include SanLI (Myanmar.), KHB (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Bio-Rad Laboratories, Inc. (U.S), Kabe Labortechnik GmbH (Germany), NIPRO Medical Corporation (Japan), Qiagen NV (Netherlands), Sarstedt AG & Co (U.S.), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Greiner Bio One International GmbH (Greiner Group) (Austria), Becton, Dickinson and Company (U.S), Terumo Medical Corporation (Japan), Medtronic Plc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), Improve Medical Technology Co. Ltd. (U.S.), Sekisui Chemical Co., Ltd. (Japan), Hongyu Medical (China), Narang Medical (India), Vital Diagnostice (ELITech Group) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), CDRICH (China), Biosigma (U.S.), Soya Green Tec Co., Ltd. (South Korea), and F.L. Medical (Italy).

Industry Updates

March 2019- Becton Dickinson & Co., a medical technology company, announced that the US FDA had granted pre-market approval for its new Venovo stent. The new device is ideally suited for the treatment of iliofemoral occlusive disease and specially designed to address the challenges associated with venous lesions.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Wednesday, 5 May 2021

Diabetic Retinopathy Market Trends, Global Demand to Forecast

Diabetic Retinopathy Market Driven by Growing Prevalence of Diabetes

Growing Prevalence of Diabetes to Drive Diabetic Retinopathy Market

The global diabetic retinopathy market is expected to exhibit a strong 11.9% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global diabetic retinopathy market was valued at USD 1.3 trillion in 2018.

Diabetic retinopathy is diabetes-associated damage caused to the eyes. Diabetes can have an adverse impact on eye health, as high sugar volume in the blood can result in damage to the blood vessels, especially weaker and thinner blood vessels. As the blood vessels in the eyes are usually thin and thus weak, diabetes can heavily affect these blood vessels and cause them to be blocked or ruptured. This causes a variety of conditions known by the umbrella term of diabetic retinopathy. This can also result in the growth of new, abnormal blood vessels on the retina, leading to further complications. The symptoms of diabetic retinopathy include vision loss, impaired color vision, blurred vision, floaters, or dark or empty areas in the vision. Complications associated with diabetic retinopathy include blindness, glaucoma, retinal detachment, and vitreous hemorrhage. The high severity of these complications has resulted in diabetic retinopathy being taken seriously by patients suffering from or at risk of contracting diabetes.

The growing prevalence of diabetes is likely to be a major driver for the global diabetic retinopathy market over the forecast period. Due to the increasing prevalence of a sedentary lifestyle and the increasing consumption of fast food and junk food, the prevalence of diabetes has grown rapidly in the last few decades. Developing regions such as Asia Pacific have become a major center for the growth in prevalence of diabetes, with increasing numbers of patients being found in APAC nations such as China, Thailand, and India. This is likely to remain a major driver for the global diabetic retinopathy market over the forecast period. The increasing geriatric population around the world is also likely to be a major driver for the global diabetic retinopathy market over the forecast period, as geriatrics suffer from weak musculature, including the muscles and tissues around the eyes.

Competitive Leaderboard:

Leading players in the global diabetic retinopathy market include Abbott Laboratories, Allergan plc, Aurolab, Ampio Pharmaceuticals Inc., Alimera Sciences, Regeneron Pharmaceuticals Inc., and F. Hoffman-La Roche AG. Strategic acquisitions and collaborations are likely to remain promising avenues for players in the global diabetic retinopathy market over the forecast period. Product launches and capacity expansion are also major avenues for players in the global diabetic retinopathy market.

Segmentation:

The global diabetic retinopathy market is segmented on the basis of type, treatment, end user, and region.

By type, the global diabetic retinopathy market is segmented into non-proliferative and proliferative. Non-proliferative diabetic retinopathy holds a dominant share in the global diabetic retinopathy market and is likely to remain in the lead over the forecast period. Proliferative diabetic retinopathy is usually the terminal version of diabetic retinopathy.

By treatment, the global diabetic retinopathy market is segmented into anti-VEGF drugs, laser photocoagulation, vitroretinal surgery, Anti-VEGF drugs are likely to remain one of the dominant segments of the global diabetic retinopathy market over the forecast period. Vitreoretinal surgery is also likely to increase in demand over the forecast period.

By end user, the global diabetic retinopathy market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment holds the dominant share in the global diabetic retinopathy market.

Regional Analysis:

The Americas hold the dominant share in the global diabetic retinopathy market and are likely to remain the leading segment over the forecast period. The growing prevalence of diabetes in North America is the major driver for the Americas market for diabetic retinopathy. Increasing awareness about diabetic retinopathy in the region is also another major driver for the global diabetic retinopathy market.

Europe holds the second largest share in the global diabetic retinopathy market, followed by Asia Pacific. Asia Pacific is likely to exhibit the fastest growth over the forecast period.

Access Report Details @ https://www.marketresearchfuture.com/reports/diabetic-retinopathy-market-5792

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Venous Blood Collection Devices Market Analysis, COVID-19 Pandemic Impact, Growth, Opportunity Assessment and Trends by Forecast 2027

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5761

Venous Blood Collection Devices Market Segmentation

The global venous blood collection devices market has been segmented based on type, material, application, and end user.

By material, the global blood collection devices market has been segmented into plastic, glass, stainless steel, ceramic, and others.

By end user, the global venous blood collection devices market has been segmented into hospitals and clinics, blood donation centers, the point of care, diagnostic centers, and others.

Venous Blood Collection Devices Market Regional Analysis

By region, the global venous blood collection devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Europe ranks second in the global venous blood collection devices market. High-income population and deep healthcare penetration in the region are favoring the growth of the market in Europe.

Competitive Landscape

Industry Updates

Browse Complete Report @ https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Breast Imaging Market 2021 | Latest Innovations, COVID-19 Impact Analysis, Revenue, Price and Gross Margin Study with Forecast to 2027

Market Synopsis

Breast imaging is a diagnostic procedure used in discerning the presence of malignant tumors near the breast in men and women. Some of the procedures include magnetic resonance imaging (MRI), computed tomography (CT), mammography, and others. The global breast imaging market report by Market Research Future (MRFR) contains historical trends and current drivers with an enumerated list of trends, opportunities, and challenges for making it easier for readers to digest the information.

The global breast imaging market is considered to demonstrate 8.5% CAGR during the forecast period (2017-2023) owing to increasing prevalence of breast cancer, asserts Market Research Future (MRFR). Breast imaging is referred to a diagnostic procedure which evaluates the presence of breast tumor in women. Breast biopsy ultrasound, mammography, PET, CT, MRI, tactile imaging, and others are some of the common breast imaging procedures. Among these, mammography is the most widely used screening tool and diagnosis for breast cancer and helps to detect breast cancer at an early stage. According to the World Health Organization, breast cancer has been reported as the second most common cancer among the women population.

Get Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/5612

Drivers and Constraints Impacting the Market

With the rising prevalence of breast cancer, the global breast imaging market is anticipated to flourish during the assessment period. More than 200,000 new cases of cancer are diagnosed every year across the globe. The increasing expenditure on healthcare by the developed countries coupled with the technological developments in the field of oncology across the world has further contributed to the market growth. Moreover, the emergence of new imaging technologies for screening and diagnosis of several chronic diseases have influenced the market growth to a great extent. Several companies conduct corporate social responsibility activities to help women educate regarding breast health and its preventive measures. For instance, companies like GE Healthcare have recently launched a commercial regarding the awareness of breast density and its effect on screening techniques. With the increasing awareness, the demand for breast imaging is predicted to expand in during the appraisal period.

On the flip side, the high cost of breast imaging solutions coupled with the unawareness about breast imaging among the women population are predicted to dampen the market growth during the estimated period. Moreover, most of the women are reluctant to undergo breast imaging owing to a number of misconceptions about the disease. This is considered to restrict the market growth in the coming years.

Global Breast Imaging Market: Segmental Analysis

The global breast imaging market has been segmented on the basis of type, application, deployment, end-user, and region.

By mode of type, the global breast imaging market has been segmented into CT, mammography, MRI, PET, breast biopsy, ultrasound, tactile imaging, and others. Among these, the mammography segment has been further sub-segmented into full-field digital mammography (FFDM), film-screen mammography, scintimammography or molecular breast imaging, 3D mammography, and others. The breast biopsy segment has been sub-segmented into tactic core biopsy, image-guided breast biopsy, ultrasound-guided core biopsy, and others.

By mode of application, the global breast imaging market has been segmented into post-neoadjuvant chemotherapy, breast cancer diagnosis, metastatic axillary adenocarcinoma, and others.

By mode of end-user, the global breast imaging market has been segmented into diagnostic centers, hospitals, and others.

Regional Insights

Geographically, the breast imaging market span across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Among all the regions, America is considered to be the largest market for breast imaging. The growth is attributed to the growing prevalence for breast cancer, innovative imaging solutions for breast imaging, and development of new imaging devices by the major market players. The market in the North American region is driven by the extensive use of imaging modalities like CT, mammography, and MRI for screening of breast cancer. The U.S. is considered to hold the largest market share owing to the presence of major players coupled with emphasis on women healthcare.

The European market is presumed to exhibit a significant growth owing to an increased expenditure on research and development activities by the major countries like U.K. The market in Germany is expanding at a substantial rate owing to an extensive use of available imaging technologies for breast imaging coupled with the exponential growth of medical devices industry. Moreover, the urge of developing new imaging devices for early cancer screening is also considered to contribute to the market growth in this region.

The Asia Pacific region showcases numerous growth opportunities owing to the presence of some of the largest contributors such as China, Japan, and India. With rising awareness about breast cancer along with the use of medical devices for cancer screening, the breast imaging market is likely to accelerate in this region. Moreover, the rapid growth of healthcare imaging industry in China and India and rising government support for improvement in the diagnostic services and healthcare infrastructure contributes to the market growth.

Industry Updates

December 04, 2018: The Ultrasound Breast Imaging Center has opened in Walnut Creek. This ultrasound 3D breast imaging involves no compression, no radiation, and no injections.

Competitive Dashboard

The prominent players operating the global breast imaging market are Sonocine Inc. (U.S.), Fujifilm Holdings Corporation (Japan), General Electric Company (U.K.), Hologic Inc. (U.S.), Dilon Technologies Inc. (U.S.), Gamma Medica Inc. (U.S.), Toshiba Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Siemens (Germany), Aurora Imaging Technology Inc. (U.S.), and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/breast-imaging-market-5612

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Dermal fillers Market 2021 | Trends, Share, Size, Growth Insight, Leading Players, Competitive Analysis, Emerging Technologies, Regional Demand and Forecast

Dermal Fillers Market Overview

Market Research Future (MRFR) studied the global dermal fillers market 2020 through the review period from 2016 to 2025. By 2025, the dermal fillers market is expected to thrive at 13.2% CAGR. The global dermal fillers market value is expected to rise exponentially due to growing preference for non-invasive aesthetic surgeries among people. The expansion of the global dermal fillers market can be attributed to increasing trend of anti-ageing treatmentsand face-lifting dermatology procedures. The growing awareness about several skin care solutions available in the market and extensive demand for diagnostic and treatment solutions for skin disorders can also influence the expansion of the dermal filler market in the near future.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/3893

The increase in awareness about harmful impact of fillers post-surgery can pose threat to the market rise in the years ahead. In addition, high expense of aesthetic surgeries can hamper the derma fillers market growth, along with the presence of several unregistered practitioners. However, increase in success rate of surgeries can counter the market slow-down in the approaching years.

Dermal Fillers Market Segmentation Study

The segment analysis of the global derma fillers market is studied by type, brand, and application. Segment insights of the derma filler market offers comprehensive analysis to investors that aid them explore untapped market potential.

The type-based segments of the global dermal fillers market are collagen, hyaluronic acid, calcium hydroxylapatite, and polymers & particles. The hyaluronic acid segment is expected to rise at the highest CAGR in the study period as the demand for anti-ageing solutions is high. The segment is expected to acquire considerable market value of USD 1,154.96 Mn in 2018. Innovations and new launches of hyaluronic acid products can benefit the market in the review tenure. The calcium hydroxylapatite can generate considerable financial gains for the global market during the analysis tenure.

The application-based segments of the dermal fillers market are lip treatment,dermal fillers, and facial line correction treatment. The lip treatment segment can acquire substantial market value by 2025. The upscaling demand for different types of aesthetic-boosting beauty solutions and rise in consciousness about beauty in women are expected to fuel the application segments expansion in the review period. The lip treatment segment is likely to rise at high pace as lip surgeries are becoming popularity among people. Moreover, lip surgeries are sought-after treatment among celebrities. The facial line correction segment can have considerable financial gain for the market in the near future.

Coronavirus Outbreak and Dermal Fillers Market @ https://www.marketresearchfuture.com/report/covid-19-impact-dermal-fillers-market

Dermal Fillers Market Regional Analysis

In North America, the surge in number of people undergoing cosmetic surgeries is expected to favor the regional derma fillers market. Alterations in lifestyle is likely to accelerate the market surge in the near future. The introduction of effective cosmetic solutions and development in dermal fillers technologies can favor the regional market. The adoption of effective product differentiation strategies for sustainable development can also strengthen the regional presence of the derma filler market in North America. The US is likely to lead North America market in the near future.

In Europe, the rise in number of facial injectable surgeries among both women and men can boost the market growth in the near future. In Asia Pacific, the availability of highly skilled healthcare professional, such as; surgeons and dermatologist, can increase the demand for dermal fillers and other dermatology appliances and devices. The high sales of dermal fillers solution in APAC can benefit the regional market in the years to come.

MEA derma filler market is likely to exhibit the slowest growth pace due to limited access to cosmetic facilities that are available in the market. However, investors exploring untapped market opportunities in the region and funding new products launches can promote the derma fillers market in Middle East Asia. In the Africa region, the market growth curve can show lag due to beauty norms in underdeveloped nations. On the contrary, regions, such as; Saudi Arabia, and Kuwait are predicted to contribute significantly to fostering the regional market growth

List of Key Players Covered in the Report

Galderma Laboratories, LP (Switzerland)
Allergan (Ireland)
Merz Pharma (Germany)
Dr. Korman Laboratories (Israel)
Sinclair Pharma (UK)
Teoxane Laboratories (Switzerland)
Suneva Medical (US)
SciVision Biotech Inc. (Taiwan)
Medytox (South Korea)

Browse In-depth Market Research Report (78 pages) on Dermal Fillers Market @ https://www.marketresearchfuture.com/reports/dermal-fillers-market-3893

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Friday, 7 May 2021

Animal Genetics Market Size, Share, Global Trends, Revenue Analysis, Business Insights, Developments and Opportunity Assessment by 2027

Biosimilars Market Share, Industry Size, Growth Analysis, Competitive Landscape, Segmentation, Future Prospects and Regional Forecast 2027

Venous Blood Collection Devices Market 2027– Global Industry Size, share, Business Insights

Wednesday, 5 May 2021

Diabetic Retinopathy Market Trends, Global Demand to Forecast

Venous Blood Collection Devices Market Analysis, COVID-19 Pandemic Impact, Growth, Opportunity Assessment and Trends by Forecast 2027

Breast Imaging Market 2021 | Latest Innovations, COVID-19 Impact Analysis, Revenue, Price and Gross Margin Study with Forecast to 2027

Dermal fillers Market 2021 | Trends, Share, Size, Growth Insight, Leading Players, Competitive Analysis, Emerging Technologies, Regional Demand and Forecast

Blog Archive

Total Pageviews